Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
TCN-032
BIOLOGICAL
2 trials
Sponsors
Theraclone Sciences, Inc.
Conditions
Influenza
Influenza, Human
Phase 1
Safety Study of Anti-Influenza Virus Monoclonal Antibody to Treat Influenza
Completed
NCT01390025
Theraclone Sciences, Inc.
Influenza, Human
Start: 2011-09-30
End: 2012-03-31
Updated: 2012-04-02
Phase 2
Influenza Virus Challenge Study to Test Monoclonal Antibody TCN-032 as a Treatment for Influenza
NCT01719874
Theraclone Sciences, Inc.
Influenza
Start: 2012-08-31
End: 2013-03-31
Target: 64
Updated: 2012-11-01
Related Papers
Efficacy and Safety of Treatment With an Anti-M2e Monoclonal Antibody in Experimental Human Influenza
The Journal of Infectious Diseases
2014-10-03
128 citations